BAYER

BAYER AFRIN 0.5MG/ML NASAL SPRAY

You're reading an Auto-translation.

Composition

The active substance is oxymetazoline hydrochloride 0.5 mg/ml. The other components are disodium edetate, anhydrous disodium phosphate, sodium dihydrogen phosphate monohydrate, povidone K 29-32, benzalkonium chloride, polyethylene glycol 1450, purified water, benzyl alcohol, microcrystalline cellulose and croscarmellose sodium, lemon flavor.

Therapeutic indications

Afrin is used to relieve symptoms of nasal congestion caused by allergic rhinitis, common cold, and sinusitis. It is administered every 12 hours. The active substance is oxymetazoline hydrochloride.

Dosage and administration

Adults, children and adolescents over 10 years of age: 1-2 sprays in each nostril, every 12 hours.

Children aged between 6 and 10 years: 1 spray in each nostril, every 12 hours.

It is not recommended to administer more than 8 sprays for adults (4 sprays for children) within a 24-hour period. The recommended dose should not be exceeded.

Afrin should not be used for more than 7 days, unless your doctor has recommended it. A few days' break should be observed before re-administering the medication.

Shake vigorously before use. Before the first administration, prepare the bottle by pressing the pump several times until the first full spray is released. While holding the bottle upright, insert the spray pump into each nostril in turn and press firmly 1-2 times, while inhaling deeply.

Clean the pump after use. The use of this medication by more than one person can lead to the spread of infection.

Precautions

If Afrin is used for a prolonged period, it may cause a sensation of nasal congestion. Use for more than one week is not recommended. Contact your doctor if symptoms worsen or do not improve after 7 days.

Special warnings

Pregnancy, lactation, fertility

Oxymetazoline has not been associated with adverse effects on the fetus. Afrin can be used in pregnant women if administered as recommended. Caution is advised in patients with high blood pressure or signs of decreased blood circulation in the placenta. Frequent or prolonged use of high doses may decrease blood circulation in the placenta.

It is not known whether oxymetazoline is excreted in breast milk. In the absence of data regarding the use of oxymetazoline during breastfeeding, Afrin should not be used during breastfeeding.

Driving and operating machinery

It has no influence on the ability to drive vehicles and operate machinery.

Packaging

Afrin is a solution in a white, light-resistant, high-density plastic bottle of 15 ml, closed with a white plastic spray pump.

Page updated on: 08.06.2021